Genmab ends work on ADC from $1.8B acquisition of ProfoundBionews2025-09-15T23:28:14+00:00September 15th, 2025|Endpoints News|
Covid-19 vaccine makers sidelined ahead of upcoming ACIP meeting, sources saynews2025-09-15T21:22:10+00:00September 15th, 2025|Endpoints News|
Bristol Myers to sell 60% stake in China-US joint venturenews2025-09-15T20:00:53+00:00September 15th, 2025|Endpoints News|
RFK Jr. adds five new ACIP panelists ahead of key meetingnews2025-09-15T19:46:29+00:00September 15th, 2025|Endpoints News|
AbbVie loses appeal over Mississippi 340B state lawnews2025-09-15T19:00:34+00:00September 15th, 2025|Endpoints News|
FDA calls out AstraZeneca’s flu vaccine TV ad amid regulatory blitznews2025-09-15T18:25:20+00:00September 15th, 2025|Endpoints News|
Pharma mulls UK divestments as government action lags in life sciencesnews2025-09-15T17:48:49+00:00September 15th, 2025|Endpoints News|
AI startup Lila Sciences raises $235M Series Anews2025-09-15T15:23:38+00:00September 15th, 2025|Endpoints News|
aTyr Pharma’s stock plummets after Phase 3 flop in inflammatory lung diseasenews2025-09-15T15:11:26+00:00September 15th, 2025|Endpoints News|
FDA expands label for Krystal’s gene therapy; The latest on Novo Nordisk’s Wegovynews2025-09-15T14:40:33+00:00September 15th, 2025|Endpoints News|
